Home
Conditions
Waldenstrom's Macroglobulinemia

Clinical trial condition

Waldenstrom's Macroglobulinemia

Explore clinical trials studying Waldenstrom's Macroglobulinemia. Study availability and eligibility vary by location and protocol.

30 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Waldenstrom's Macroglobulinemia trial results

Completed

Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia

NCT00142116

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

NCT00807677

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Polycythemia, +47 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia

NCT00142181

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Beth Isreal Deaconness Medical Center Boston, Massachusetts, United States

Dana-farber Cancer Insitiute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood

NCT00146055

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +21 more
Locations: The University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Trial of AVN-944 in Patients With Advanced Hematologic Malignancies

NCT00273936

Conditions: Acute Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations: Arizona Clinical Research Center Tucson, Arizona, United States

Stanford Cancer Center Stanford, California, United States

George Washington University Washington D.C., District of Columbia, United States

Ohio State University, James Cancer Hospital Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Sildenafil Citrate in Waldenstrom's Macroglobulinemia

NCT00165295

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Bortezomib (Velcade) in Waldenstrom's Macroglobulinemia

NCT00142129

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Dana-Farber Cancer Center Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

NCT00142155

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders

NCT01177527

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +23 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

NCT00492050

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Waldenstrom's Macroglobulinemia

Waldenstrom's Macroglobulinemia trial results

Related conditions